ArticleFrontiers in oncology2026
Technical evaluation of non-coplanar lattice radiotherapy: achieving directional VPDR uniformity with a 5-mm leaf width multi-leaf collimator.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Spatially fractionated radiation therapy (SFRT) creates alternating high-dose peaks and low-dose valleys for treating bulky tumors, with optimal biological effects associated with sufficient spatial dose modulation across the tumor volume. Coplanar lattice radiotherapy (LRT) demonstrated significant directional imbalance: superior-inferior VPDR was 2.7-fold lower (14.5%) than anterior-posterior and lateral directions (approximately 40%), with transverse directions exceeding the dosimetric range commonly reported in prior LRT studies. This study systematically evaluated non-coplanar LRT to quantify directional VPDR uniformity improvements using the Millennium 120 multi-leaf collimator. Methods: A 3×3×3 lattice structure with 27 vertices was implemented in a cylindrical phantom across 20 geometric configurations: vertex diameters 0.5-2.0 cm and separations 1.0-5.0 cm. Four non-coplanar arcs utilized couch angles of 0°, 315°, 45°, and 90° with consistent 45°collimator angle, optimized using Eclipse HyperArc. VPDR was analyzed in three orthogonal directions, normal tissue dose characteristics were assessed, and treatment delivery efficiency was evaluated through monitor unit distribution patterns and modulation complexity scores. Results: Direct comparison with coplanar delivery demonstrated substantial improvements in directional uniformity. For representative 1.5 cm diameter with 2.0 cm separation, non-coplanar delivery maintained superior-inferior VPDR at 26.4 ± 5.3% while reducing excessive transverse direction values from approximately 40% (coplanar) to 27.6 ± 1.5% and 25.8 ± 3.5% (non-coplanar), bringing all directions within the dosimetric range commonly reported in prior LRT studies. Excessively high transverse VPDR values (38-44% in coplanar) were reduced, achieving directionally balanced VPDR values across all vertex diameters. Normal tissue intersection volumes with high-dose regions achieved zero at separations ≥2.0 cm for 1.0 cm diameter and ≥3.0 cm for 0.5 cm diameter. Monitor unit distribution remained balanced across couch angles. Conclusions: Non-coplanar delivery successfully brought all three directional VPDR values within the dosimetric range commonly reported in prior LRT studies at separations ≥2.0 cm across vertex diameters, addressing the excessive transverse direction VPDR (>40%) observed in coplanar delivery. This advancement enables directionally balanced SFRT dose distribution in all directions, critical for uniform spatial fractionation effectiveness. This systematic evaluation provides quantitative evidence and parameter selection guidance for clinical implementation using conventional medical linear accelerators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.